FDA's 21st Century Cures Plan Gives Patient-Focused Drug Development A Boost

US agency will hold five workshops and develop seven guidance documents focused on patient input in the drug development and review process; since some guidance requirements under Cures law overlap with those in PDUFA VI commitment letter, most of the funding will come from user fees.

FDA entrance sign 2016

FDA's plan for issuing the patient-focused drug development guidance documents required under the 21st Century Cures Act includes numerous public workshops and a slightly more aggressive timeframe for some draft guidances than required under the pending agreement to reauthorize the Prescription Drug User Fee Act (PDUFA VI).

In total, the schedule FDA lays out in its "Plan for Issuance of Patient-Focused Drug Development Guidance Under 21st Century...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legislation

More from Pink Sheet